[
  {
    "id": "fc_tb_drtb_e298bf03",
    "front": "IPF PH classification?",
    "back": "Group 3 pulmonary hypertension (CLD-PH).",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Drug-Resistant TB (MDR/XDR)",
    "bookId": "tb_drtb",
    "sourceSection": null,
    "sourceLocation": {
      "bookName": "30.TUBERCULOSIS INTEGRATED SESSION 2 (1)",
      "chapter": "Interpretation",
      "section": null,
      "pageNumber": 30
    }
  },
  {
    "id": "fc_tb_drtb_c9d9d67f",
    "front": "IPF PH treatment priorities?",
    "back": "Optimal IPF management, correct hypoxemia, lung transplant.",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Drug-Resistant TB (MDR/XDR)",
    "bookId": "tb_drtb",
    "sourceSection": null,
    "sourceLocation": {
      "bookName": "30.TUBERCULOSIS INTEGRATED SESSION 2 (1)",
      "chapter": "Interpretation",
      "section": null,
      "pageNumber": 30
    }
  },
  {
    "id": "fc_tb_drtb_46d804e3",
    "front": "Angiotensin II inhibitors beneficial in what PH?",
    "back": "CLD-PH, especially idiopathic pulmonary fibrosis (IPF).",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Drug-Resistant TB (MDR/XDR)",
    "bookId": "tb_drtb",
    "sourceSection": null,
    "sourceLocation": {
      "bookName": "30.TUBERCULOSIS INTEGRATED SESSION 2 (1)",
      "chapter": "Interpretation",
      "section": null,
      "pageNumber": 30
    }
  },
  {
    "id": "fc_tb_drtb_af8e4f64",
    "front": "ACE inhibitors attenuate what pulmonary response?",
    "back": "Hypoxic pulmonary vasoconstriction (HPV).",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Drug-Resistant TB (MDR/XDR)",
    "bookId": "tb_drtb",
    "sourceSection": null,
    "sourceLocation": {
      "bookName": "30.TUBERCULOSIS INTEGRATED SESSION 2 (1)",
      "chapter": "Interpretation",
      "section": null,
      "pageNumber": 30
    }
  },
  {
    "id": "fc_tb_drtb_701629b5",
    "front": "CT main PA diameter diagnose advanced IPF PH?",
    "back": "No; failed to differentiate PH in advanced IPF.",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Drug-Resistant TB (MDR/XDR)",
    "bookId": "tb_drtb",
    "sourceSection": null,
    "sourceLocation": {
      "bookName": "30.TUBERCULOSIS INTEGRATED SESSION 2 (1)",
      "chapter": "Interpretation",
      "section": null,
      "pageNumber": 30
    }
  },
  {
    "id": "fc_tb_drtb_51437629",
    "front": "IPF falls into which PH group?",
    "back": "Group 3 (Chronic Lung Disease PH)",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Drug-Resistant TB (MDR/XDR)",
    "bookId": "tb_drtb",
    "sourceSection": null,
    "sourceLocation": {
      "bookName": "30.TUBERCULOSIS INTEGRATED SESSION 2 (1)",
      "chapter": "Interpretation",
      "section": null,
      "pageNumber": 30
    }
  },
  {
    "id": "fc_tb_drtb_374d5ab2",
    "front": "RAAS inhibitors beneficial in which CLD-PH?",
    "back": "Idiopathic Pulmonary Fibrosis (IPF)",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Drug-Resistant TB (MDR/XDR)",
    "bookId": "tb_drtb",
    "sourceSection": null,
    "sourceLocation": {
      "bookName": "30.TUBERCULOSIS INTEGRATED SESSION 2 (1)",
      "chapter": "Interpretation",
      "section": null,
      "pageNumber": 30
    }
  },
  {
    "id": "fc_tb_drtb_70318163",
    "front": "ACEi/ARBs effect on hypoxic pulmonary vasoconstriction?",
    "back": "Attenuate (reduce) HPV",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Drug-Resistant TB (MDR/XDR)",
    "bookId": "tb_drtb",
    "sourceSection": null,
    "sourceLocation": {
      "bookName": "30.TUBERCULOSIS INTEGRATED SESSION 2 (1)",
      "chapter": "Interpretation",
      "section": null,
      "pageNumber": 30
    }
  },
  {
    "id": "fc_tb_drtb_ce24a201",
    "front": "CT: Pulmonary artery diameter suggestive of PH?",
    "back": "> 29 mm",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Drug-Resistant TB (MDR/XDR)",
    "bookId": "tb_drtb",
    "sourceSection": null,
    "sourceLocation": {
      "bookName": "30.TUBERCULOSIS INTEGRATED SESSION 2 (1)",
      "chapter": "Interpretation",
      "section": null,
      "pageNumber": 30
    }
  },
  {
    "id": "fc_tb_drtb_559111bb",
    "front": "CT PA diameter differentiates PH in IPF?",
    "back": "No (failed to differentiate)",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Drug-Resistant TB (MDR/XDR)",
    "bookId": "tb_drtb",
    "sourceSection": null,
    "sourceLocation": {
      "bookName": "30.TUBERCULOSIS INTEGRATED SESSION 2 (1)",
      "chapter": "Interpretation",
      "section": null,
      "pageNumber": 30
    }
  },
  {
    "id": "fc_tb_drtb_abdb9c83",
    "front": "IPF PH classification group?",
    "back": "Group 3 (CLD-PH)",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Drug-Resistant TB (MDR/XDR)",
    "bookId": "tb_drtb",
    "sourceSection": null,
    "sourceLocation": {
      "bookName": "30.TUBERCULOSIS INTEGRATED SESSION 2 (1)",
      "chapter": "Interpretation",
      "section": null,
      "pageNumber": 30
    }
  },
  {
    "id": "fc_tb_drtb_0ebdb527",
    "front": "Angiotensin II inhibitors benefit in IPF?",
    "back": "Lower PVR; beneficial in CLD-PH, especially IPF",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Drug-Resistant TB (MDR/XDR)",
    "bookId": "tb_drtb",
    "sourceSection": null,
    "sourceLocation": {
      "bookName": "30.TUBERCULOSIS INTEGRATED SESSION 2 (1)",
      "chapter": "Interpretation",
      "section": null,
      "pageNumber": 30
    }
  },
  {
    "id": "fc_tb_drtb_41810a48",
    "front": "CT main PA diameter for IPF PH?",
    "back": "Failed to differentiate PH in advanced IPF",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Drug-Resistant TB (MDR/XDR)",
    "bookId": "tb_drtb",
    "sourceSection": null,
    "sourceLocation": {
      "bookName": "30.TUBERCULOSIS INTEGRATED SESSION 2 (1)",
      "chapter": "Interpretation",
      "section": null,
      "pageNumber": 30
    }
  },
  {
    "id": "fc_tb_drtb_baed7d77",
    "front": "IPF-PH primary management?",
    "back": "Optimal lung disease management, hypoxemia, lung transplant",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Drug-Resistant TB (MDR/XDR)",
    "bookId": "tb_drtb",
    "sourceSection": null,
    "sourceLocation": {
      "bookName": "30.TUBERCULOSIS INTEGRATED SESSION 2 (1)",
      "chapter": "Interpretation",
      "section": null,
      "pageNumber": 30
    }
  },
  {
    "id": "fc_tb_drtb_69cbe4f6",
    "front": "PAH medications for IPF-PH efficacy?",
    "back": "Generally lack efficacy; may cause harm",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Drug-Resistant TB (MDR/XDR)",
    "bookId": "tb_drtb",
    "sourceSection": null,
    "sourceLocation": {
      "bookName": "30.TUBERCULOSIS INTEGRATED SESSION 2 (1)",
      "chapter": "Interpretation",
      "section": null,
      "pageNumber": 30
    }
  },
  {
    "id": "fc_tb_drtb_615a1dac",
    "front": "CLD-PH: Angiotensin II inhibitors beneficial in?",
    "back": "Idiopathic Pulmonary Fibrosis (IPF)",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Drug-Resistant TB (MDR/XDR)",
    "bookId": "tb_drtb",
    "sourceSection": null,
    "sourceLocation": {
      "bookName": "30.TUBERCULOSIS INTEGRATED SESSION 2 (1)",
      "chapter": "Interpretation",
      "section": null,
      "pageNumber": 30
    }
  },
  {
    "id": "fc_tb_drtb_31e22715",
    "front": "IPF-PH: CT main pulmonary artery diameter?",
    "back": "Fails to differentiate PH by RHC",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Drug-Resistant TB (MDR/XDR)",
    "bookId": "tb_drtb",
    "sourceSection": null,
    "sourceLocation": {
      "bookName": "30.TUBERCULOSIS INTEGRATED SESSION 2 (1)",
      "chapter": "Interpretation",
      "section": null,
      "pageNumber": 30
    }
  },
  {
    "id": "fc_tb_drtb_4b98ad1d",
    "front": "MC ILD pattern in CTDs?",
    "back": "NSIP (except Rheumatoid Arthritis: UIP)",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Drug-Resistant TB (MDR/XDR)",
    "bookId": "tb_drtb",
    "sourceSection": null,
    "sourceLocation": {
      "bookName": "30.TUBERCULOSIS INTEGRATED SESSION 2 (1)",
      "chapter": "Interpretation",
      "section": null,
      "pageNumber": 30
    }
  },
  {
    "id": "fc_tb_drtb_5fc347ea",
    "front": "NSIP often linked to what disease group?",
    "back": "Undifferentiated connective tissue disease (CTD)",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Drug-Resistant TB (MDR/XDR)",
    "bookId": "tb_drtb",
    "sourceSection": null,
    "sourceLocation": {
      "bookName": "30.TUBERCULOSIS INTEGRATED SESSION 2 (1)",
      "chapter": "Interpretation",
      "section": null,
      "pageNumber": 30
    }
  },
  {
    "id": "fc_tb_drtb_211a8c83",
    "front": "NSIP IIP classification category?",
    "back": "Chronic Fibrosing IPs",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Drug-Resistant TB (MDR/XDR)",
    "bookId": "tb_drtb",
    "sourceSection": null,
    "sourceLocation": {
      "bookName": "30.TUBERCULOSIS INTEGRATED SESSION 2 (1)",
      "chapter": "Interpretation",
      "section": null,
      "pageNumber": 30
    }
  },
  {
    "id": "fc_tb_drtb_ee94473f",
    "front": "COP, AIP IIP classification category?",
    "back": "Acute/Subacute IPs",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Drug-Resistant TB (MDR/XDR)",
    "bookId": "tb_drtb",
    "sourceSection": null,
    "sourceLocation": {
      "bookName": "30.TUBERCULOSIS INTEGRATED SESSION 2 (1)",
      "chapter": "Interpretation",
      "section": null,
      "pageNumber": 30
    }
  },
  {
    "id": "fc_tb_drtb_690e8f16",
    "front": "Smoking-related IIP examples?",
    "back": "Respiratory Bronchiolitis-ILD (RB-ILD), Desquamative IP (DIP)",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Drug-Resistant TB (MDR/XDR)",
    "bookId": "tb_drtb",
    "sourceSection": null,
    "sourceLocation": {
      "bookName": "30.TUBERCULOSIS INTEGRATED SESSION 2 (1)",
      "chapter": "Interpretation",
      "section": null,
      "pageNumber": 30
    }
  }
]